PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
6226942-5	1983	Serum LH, prolactin, and testosterone levels in Copenhagen F-1 rats bearing Dunning tumors were significantly decreased after treatment with D-Trp6-LH-RH as well as the antagonist.	Testosterone	25-37	transient receptor potential cation channel subfamily C member 6	Homo sapiens	143-147	
7541770-4	1995	After initial stimulation of the pituitary, administration of a depot preparation of D-Trp-6-GnRH resulted in a constant decrease in gonadotropin and sex steroid concentrations with LH and testosterone concentrations remaining within the limits of prepubertal levels from days 16 to 48.	Testosterone	189-201	transient receptor potential cation channel subfamily C member 6	Homo sapiens	87-92	
2947053-4	1986	Treatment with D-Trp-6-LH-RH greatly reduced serum LH and testosterone levels without raising serum prolactin.	Testosterone	58-70	transient receptor potential cation channel subfamily C member 6	Homo sapiens	17-22	
2866289-6	1985	3 patients given D-Trp-6-LHRH had a disease "flare" in the first ten days of treatment which resolved completely when testosterone fell to castrate levels.	Testosterone	118-130	transient receptor potential cation channel subfamily C member 6	Homo sapiens	19-24	
6428479-1	1984	To elucidate whether the luteinizing hormone-releasing hormone (LHRH) analog D-Trp6-Pro9-NEt-LHRH (LHRHa) decreases plasma testosterone levels in male primates solely by inhibiting gonadotropin secretion or, in addition, by inhibiting testicular testosterone biosynthesis, we have investigated the effects of this drug on 6 infant male rhesus monkeys.	Testosterone	123-135	transient receptor potential cation channel subfamily C member 6	Homo sapiens	79-83	
20415-8	1977	Following the administration of the D-Trp6-LH-RH, testosterone levels were maintained above the normal values (P less than 0.02).	Testosterone	50-62	transient receptor potential cation channel subfamily C member 6	Homo sapiens	38-42